Back
Ikena Oncology 10K Form
Buy
68
IKNA
Ikena Oncology
Last Price:
$1.43
Seasonality Move:
-2.3%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IKNA News And Ratings
See the #1 stock for the next 7 days that we like better than IKNA
IKNA Financial Statistics
Sales & Book Value
| Annual Sales: | $9.2M |
|---|---|
| Cash Flow: | $-10.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.45 |
| Price / Book: | 0.58 |
Profitability
| EPS (TTM): | -0.86000 |
|---|---|
| Net Income (TTM): | $-41.7M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Ikena Oncology Earnings Forecast
Key Ikena Oncology Financial Ratios
-
Per Share Earnings over the last 6 years have been positive in 3 years.
Ikena Oncology Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | IKNA |
| Website: | ikenaoncology.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IKNA Technical Analysis vs Fundamental Analysis
Buy
68
Ikena Oncology (IKNA)
is a Buy
Is Ikena Oncology a Buy or a Sell?
-
Ikena Oncology stock is rated a BuyThe current Ikena Oncology [IKNA] share price is $1.42. The Score for IKNA is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.